Endovascular arch repair of anastomotic aneurysm and pseudoaneurysm in patients after open repair of the ascending aorta and aortic arch: a case series
European Journal of Cardio-Thoracic Surgery · 2023
DOI: 10.1093/ejcts/ezad345 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2023. Verfasst von Daniel Becker und 7 weiteren Autor:innen. Beteiligte Einrichtung: University Aortic Center Munich, LMU University Hospital, Munich, Germany. Hauptthemen laut MEDLINE: Aortic Aneurysm, Thoracic, Blood Vessel Prosthesis Implantation, Aneurysm, False, Endovascular Procedures. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES The aim of the study was to investigate the outcomes of branched endovascular arch repair (b-TEVAR) with a custom-made double- or triple-branched arch endograft in patients with distal anastomotic aneurysms after open repair of the ascending aorta or proximal arch replacement. METHODS Retrospective analysis was conducted of all consecutive patients with anastomotic aneurysms after open surgical repair involving the ascending aorta and/or aortic arch treated with b-TEVAR. All patients were treated with a custom-made double or triple inner-branched arch endograft. Study end points were technical success, 30-day and follow-up mortality/morbidity and re-interventions. RESULTS Between 2018 and 2022, 10 patients were treated with custom-made double- or triple-branched thoracic endovascular aortic repair due to anastomotic aneurysms after open ascending aorta and/or proximal aortic arch replacement. Eight patients received a triple and 2 a double arch-branched endograft. Eight cases were performed electively and 2 urgently for contained rupture. Technical success was achieved in 9 cases (90%). All elective patients survived. Two patients treated due to contained ruptures expired. Within 30 postoperative days, 1 transient ischaemic attack occurred. No early endograft-related re-interventions were necessary. The median follow-up was 20 months. One patient died 2 months after discharge due to sepsis caused by pneumonia. No further deaths or endograft-related re-interventions were observed. CONCLUSIONS Endovascular aortic arch repair with double or triple inner-branched arch endograft for anastomotic aneurysms after open ascending and/or proximal arch replacement is technically feasible and a promising alternative in a patient cohort unfit for surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Aortic Center Munich, LMU University Hospital, Munich, Germany.
- Department of Vascular Surgery, LMU University Hospital, Munich, Germany.
- Department of Cardiac Surgery, LMU University Hospital, Munich, Germany.
ORCID-Profile: Daniel Becker, Jan Stana, Carlota F Prendes, Maximilian Pichlmaier, Sven Peterss, Nikolaos Tsilimparis
Zitieren
APA
Becker, D., Stana, J., Prendes, C. F., Konstantinou, N., Öz, T., Pichlmaier, M., Peterss, S., & Tsilimparis, N. (2023). Endovascular arch repair of anastomotic aneurysm and pseudoaneurysm in patients after open repair of the ascending aorta and aortic arch: a case series. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad345
Vancouver
Becker D, Stana J, Prendes CF, Konstantinou N, Öz T, Pichlmaier M, et al. Endovascular arch repair of anastomotic aneurysm and pseudoaneurysm in patients after open repair of the ascending aorta and aortic arch: a case series. European Journal of Cardio-Thoracic Surgery. 2023. doi:10.1093/ejcts/ezad345
BibTeX
@article{Becker2023,
author = {Becker, Daniel and Stana, Jan and Prendes, Carlota F and Konstantinou, Nikolaos and Öz, Tugce and Pichlmaier, Maximilian and Peterss, Sven and Tsilimparis, Nikolaos},
title = {Endovascular arch repair of anastomotic aneurysm and pseudoaneurysm in patients after open repair of the ascending aorta and aortic arch: a case series},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2023},
doi = {10.1093/ejcts/ezad345}
}
EUVIMED